Association between low-dose aspirin and time to diagnosis: evidence from patients with hip fracture
Published
December 31, 2024
Paper ID
PAP-000059
Status
Published
DOI
10.65712/tmj.test000317
Advance Services
Abstract
Background: Earlier studies of low-dose aspirin were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: The adjusted odds ratio was 0.72 (95% CI 0.45 to 0.90). time to diagnosis occurred in 17% of the intervention group versus 32% of controls. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Guidelines make only a weak recommendation on low-dose aspirin. Earlier studies of low-dose aspirin were small or single-centre.
The cost of time to diagnosis to health systems is substantial. Earlier studies of low-dose aspirin were small or single-centre.
Earlier studies of low-dose aspirin were small or single-centre. time to diagnosis remains a leading cause of avoidable harm among patients with hip fracture.
Guidelines make only a weak recommendation on low-dose aspirin. Practice around low-dose aspirin varies widely between centres.
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Future work should test low-dose aspirin in a pragmatic multicentre trial. These findings suggest that low-dose aspirin is associated with better time to diagnosis in patients with hip fracture.
Residual confounding cannot be excluded. Future work should test low-dose aspirin in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
These findings suggest that low-dose aspirin is associated with better time to diagnosis in patients with hip fracture. Residual confounding cannot be excluded. Future work should test low-dose aspirin in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial.
Conclusions
Low-dose aspirin may be offered for patients with hip fracture to improve time to diagnosis.
References
1. Volkov E, Kowalski L, et al. Early enteral nutrition and ventilator-free days. Diabetes Care. 2018;218(2):286-1577.
2. Dubois B, Herrera W, et al. Vitamin D supplementation and glycaemic control. Ann Intern Med. 2018;261(7):817-1107.
3. Silva M, Ibrahim O, et al. SGLT2 inhibitors and health-related quality of life. JAMA. 2023;178(9):324-1023.
4. Silva H, Kowalski I, et al. Prone positioning and time to diagnosis. Lancet. 2008;180(3):138-1416.
5. Dubois E, Rahman X, et al. An antibiotic stewardship programme and acute kidney injury. Lancet. 2020;229(6):156-1200.
Appendices
Ethics approval: IRB-3661.
Materials and Methods
We conducted a retrospective cohort study across 11 centres between 2017 and 2021. Eligible participants were patients with hip fracture. Missing data were handled with multiple imputation.
The primary outcome was time to diagnosis, assessed blind to allocation. We conducted a retrospective cohort study across 9 centres between 2020 and 2021.
Results
time to diagnosis occurred in 4% of the intervention group versus 31% of controls. Effects were consistent across prespecified subgroups.
2271 participants were included (median age 52 years). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 207 | 111 |
| Intervention | 128 | 86 |
| Intervention | 119 | 79 |
Values are n (%) unless stated otherwise.

Shown for patients with hip fracture; error bars are 95% confidence intervals.

Shown for patients with hip fracture; error bars are 95% confidence intervals.
time to diagnosis occurred in 21% of the intervention group versus 22% of controls. 2686 participants were included (median age 75 years). Serious adverse events were rare and similar between groups. time to diagnosis occurred in 10% of the intervention group versus 32% of controls.
The adjusted odds ratio was 0.76 (95% CI 0.20 to 0.86). Serious adverse events were rare and similar between groups.